Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

SAB Biotherapeutics (SABS) Asset Utilization Ratio (2021 - 2025)

SAB Biotherapeutics (SABS) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio fell 105.01% year-over-year to 0.0, compared with a TTM value of 0.0 through Dec 2025, down 105.01%, and an annual FY2024 reading of 0.02, down 37.84% over the prior year.
  • Asset Utilization Ratio was 0.0 for Q4 2025 at SAB Biotherapeutics, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.75 in Q1 2022 and bottomed at 0.0 in Q4 2025.
  • Average Asset Utilization Ratio over 5 years is 0.24, with a median of 0.09 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio soared 37.68% in 2022, then plummeted 105.01% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.61 in 2021, then fell by 24.79% to 0.46 in 2022, then tumbled by 91.37% to 0.04 in 2023, then crashed by 32.33% to 0.03 in 2024, then crashed by 105.01% to 0.0 in 2025.
  • Business Quant data shows Asset Utilization Ratio for SABS at 0.0 in Q4 2025, 0.0 in Q3 2025, and 0.0 in Q2 2025.